Finding no evidence in those companies supports my
Post# of 72440
The same question can be asked in IPIX right now. If it's not nake shorting, what could be the reason? I've explained that there are no immediate catalysts yet. Once we get closer to the B-OM and P top-line results, you'll see the stock run up. As we can learn from the charts of PCYC, REGN & JAZZ, the market doesn't value the company based on potentials. Once IPIX's drugs start generating revenues through partnership or after approval, its stock will be valued more accurately.
Quote:
Could not find PCYC but when I looked at REGN and JAZZ I was unable to find any evidence that they had been attacked by abusive naked short sellers.